ATE373480T1 - Glycosaminoglykane zur behandlung emotionaler störungen - Google Patents
Glycosaminoglykane zur behandlung emotionaler störungenInfo
- Publication number
- ATE373480T1 ATE373480T1 AT04741606T AT04741606T ATE373480T1 AT E373480 T1 ATE373480 T1 AT E373480T1 AT 04741606 T AT04741606 T AT 04741606T AT 04741606 T AT04741606 T AT 04741606T AT E373480 T1 ATE373480 T1 AT E373480T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- glycosaminoglycans
- emotional disorders
- disorders
- anxiety
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001023A ITMI20031023A1 (it) | 2003-05-21 | 2003-05-21 | Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE373480T1 true ATE373480T1 (de) | 2007-10-15 |
Family
ID=30131059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04741606T ATE373480T1 (de) | 2003-05-21 | 2004-05-19 | Glycosaminoglykane zur behandlung emotionaler störungen |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7812005B2 (de) |
| EP (1) | EP1631298B8 (de) |
| JP (1) | JP4757197B2 (de) |
| KR (1) | KR20060025142A (de) |
| CN (1) | CN100377717C (de) |
| AT (1) | ATE373480T1 (de) |
| AU (1) | AU2004241748B2 (de) |
| CA (1) | CA2526201A1 (de) |
| DE (1) | DE602004009068T2 (de) |
| DK (1) | DK1631298T3 (de) |
| ES (1) | ES2294507T3 (de) |
| HK (1) | HK1084023A1 (de) |
| IL (1) | IL171981A (de) |
| IT (1) | ITMI20031023A1 (de) |
| NO (1) | NO20056089L (de) |
| NZ (1) | NZ544238A (de) |
| PL (1) | PL1631298T3 (de) |
| PT (1) | PT1631298E (de) |
| RU (1) | RU2353371C2 (de) |
| WO (1) | WO2004103381A1 (de) |
| ZA (1) | ZA200510132B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584704B (zh) * | 2008-05-23 | 2010-12-15 | 鲁南制药集团股份有限公司 | 肝素、低分子肝素可药用盐或其衍生物的医药用途 |
| CN107760713B (zh) * | 2016-08-23 | 2020-05-05 | 中国科学院上海药物研究所 | 一种非人哺乳动物神经精神疾病动物模型的建立方法及其用途 |
| CN112438991B (zh) * | 2019-08-29 | 2024-03-15 | 鲁南制药集团股份有限公司 | 肝素、或其衍生物、或其可药用盐的医药用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4351938A (en) * | 1980-05-19 | 1982-09-28 | Riker Laboratories, Inc. | Anticoagulant substance |
| US4916219A (en) * | 1985-03-28 | 1990-04-10 | University Of Iowa Research Foundation | Oligosaccharide heparin fragments as inhibitors of complement cascade |
| IT1205042B (it) | 1987-05-28 | 1989-03-10 | Crinos Industria Farmaco | Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer |
| US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| FR2763848B1 (fr) * | 1997-05-28 | 2000-01-28 | Rhone Poulenc Rorer Sa | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central |
| FR2763849B1 (fr) * | 1997-05-28 | 2000-09-15 | Rhone Poulenc Rorer Sa | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux |
| JP4412756B2 (ja) * | 1998-02-26 | 2010-02-10 | 生化学工業株式会社 | 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物 |
| IT1312107B1 (it) * | 1999-05-14 | 2002-04-04 | Umberto Cornelli | Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile |
-
2003
- 2003-05-21 IT IT001023A patent/ITMI20031023A1/it unknown
-
2004
- 2004-05-19 ES ES04741606T patent/ES2294507T3/es not_active Expired - Lifetime
- 2004-05-19 WO PCT/EP2004/050860 patent/WO2004103381A1/en active IP Right Grant
- 2004-05-19 AT AT04741606T patent/ATE373480T1/de not_active IP Right Cessation
- 2004-05-19 AU AU2004241748A patent/AU2004241748B2/en not_active Expired - Fee Related
- 2004-05-19 JP JP2006530208A patent/JP4757197B2/ja not_active Expired - Fee Related
- 2004-05-19 DK DK04741606T patent/DK1631298T3/da active
- 2004-05-19 NZ NZ544238A patent/NZ544238A/en unknown
- 2004-05-19 DE DE602004009068T patent/DE602004009068T2/de not_active Expired - Fee Related
- 2004-05-19 EP EP04741606A patent/EP1631298B8/de not_active Expired - Lifetime
- 2004-05-19 PL PL04741606T patent/PL1631298T3/pl unknown
- 2004-05-19 KR KR1020057021781A patent/KR20060025142A/ko not_active Application Discontinuation
- 2004-05-19 CA CA002526201A patent/CA2526201A1/en not_active Abandoned
- 2004-05-19 US US10/557,860 patent/US7812005B2/en not_active Expired - Fee Related
- 2004-05-19 RU RU2005138517/15A patent/RU2353371C2/ru not_active IP Right Cessation
- 2004-05-19 PT PT04741606T patent/PT1631298E/pt unknown
- 2004-05-19 CN CNB2004800136097A patent/CN100377717C/zh not_active Expired - Fee Related
-
2005
- 2005-11-15 IL IL171981A patent/IL171981A/en not_active IP Right Cessation
- 2005-12-13 ZA ZA200510132A patent/ZA200510132B/en unknown
- 2005-12-21 NO NO20056089A patent/NO20056089L/no not_active Application Discontinuation
-
2006
- 2006-04-07 HK HK06104250A patent/HK1084023A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1631298A1 (de) | 2006-03-08 |
| IL171981A (en) | 2010-04-15 |
| PT1631298E (pt) | 2007-12-31 |
| DE602004009068D1 (de) | 2007-10-31 |
| AU2004241748A1 (en) | 2004-12-02 |
| AU2004241748B2 (en) | 2010-05-13 |
| JP2006528670A (ja) | 2006-12-21 |
| WO2004103381A1 (en) | 2004-12-02 |
| NO20056089L (no) | 2006-02-09 |
| KR20060025142A (ko) | 2006-03-20 |
| EP1631298B8 (de) | 2008-12-24 |
| IL171981A0 (en) | 2006-04-10 |
| EP1631298B1 (de) | 2007-09-19 |
| US7812005B2 (en) | 2010-10-12 |
| CN100377717C (zh) | 2008-04-02 |
| JP4757197B2 (ja) | 2011-08-24 |
| DK1631298T3 (da) | 2008-01-28 |
| RU2353371C2 (ru) | 2009-04-27 |
| DE602004009068T2 (de) | 2008-06-19 |
| HK1084023A1 (en) | 2006-07-21 |
| ITMI20031023A1 (it) | 2004-11-22 |
| PL1631298T3 (pl) | 2008-04-30 |
| ITMI20031023A0 (it) | 2003-05-21 |
| CA2526201A1 (en) | 2004-12-02 |
| RU2005138517A (ru) | 2006-08-27 |
| US20060205690A1 (en) | 2006-09-14 |
| CN1791416A (zh) | 2006-06-21 |
| NZ544238A (en) | 2008-08-29 |
| ES2294507T3 (es) | 2008-04-01 |
| ZA200510132B (en) | 2006-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05009595A (es) | Compuestos 7-amino-isoindolilo y sus usos farmaceuticos. | |
| MXPA05009015A (es) | Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos. | |
| MY143390A (en) | Sulfonamide derivatives for the treatment of diseases. | |
| SE0301010D0 (sv) | Novel compounds | |
| TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
| MY147767A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
| MXPA05009304A (es) | Derivados de indol utiles para el tratamiento de enfermedades. | |
| SE0301009D0 (sv) | Novel compounds | |
| EP2182006A3 (de) | Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen | |
| CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
| ATE453636T1 (de) | Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren | |
| MY139690A (en) | Sulfonamide derivatives for the treatment of diseases. | |
| MY141476A (en) | 5ht2c receptor modulators | |
| IL188475A0 (en) | Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors | |
| TW200519075A (en) | Novel compounds | |
| JO2686B1 (en) | Vehicles | |
| EA201001821A1 (ru) | Производные триазола, полезные для лечения заболеваний | |
| EA200601462A1 (ru) | Соединения для лечения заболеваний | |
| DE502005008971D1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht | |
| TW200505862A (en) | 2-amino-pyridine derivatives useful for the treatment of diseases | |
| MY147677A (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
| SE0302139D0 (sv) | Novel compounds | |
| ATE388708T1 (de) | Piperazinderivate und anwendungsverfahren | |
| TW200505865A (en) | Compounds useful for the treatment of diseases | |
| SE0402925D0 (sv) | Novel Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1631298 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |